BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19654228)

  • 21. Dendritic cells and macrophages in kidney disease.
    Matsumoto K; Fukuda N; Abe M; Fujita T
    Clin Exp Nephrol; 2010 Feb; 14(1):1-11. PubMed ID: 19688180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell activation and immunologic synapse.
    Shaw AS
    Immunol Res; 2005; 32(1-3):247-52. PubMed ID: 16106076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system.
    Steinman RM
    Nat Med; 2007 Oct; 13(10):1155-9. PubMed ID: 17917664
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes.
    Sándor N; Pap D; Prechl J; Erdei A; Bajtay Z
    Mol Immunol; 2009 Dec; 47(2-3):438-48. PubMed ID: 19796821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell-based tumor immunotherapy.
    Kadowaki N; Kitawaki T
    Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
    [No Abstract]   [Full Text] [Related]  

  • 26. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
    Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
    Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of dendritic cell populations and regulatory T cells vary significantly between two commonly used mouse strains.
    Vogelsang P; Hovden AO; Jonsson R; Appel S
    Scand J Immunol; 2009 Dec; 70(6):541-6. PubMed ID: 19906196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.
    Luangsay S; Wittamer V; Bondue B; De Henau O; Rouger L; Brait M; Franssen JD; de Nadai P; Huaux F; Parmentier M
    J Immunol; 2009 Nov; 183(10):6489-99. PubMed ID: 19841182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The involvement of neprilysin in the pathogenesis of glomerulopathies].
    Kubiak-Wlekły A; Niemir ZI
    Pol Merkur Lekarski; 2009 Sep; 27(159):239-41. PubMed ID: 19827739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient.
    van Heijst JW; Gerlach C; Swart E; Sie D; Nunes-Alves C; Kerkhoven RM; Arens R; Correia-Neves M; Schepers K; Schumacher TN
    Science; 2009 Sep; 325(5945):1265-9. PubMed ID: 19729659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dendritic cells and glomerulonephritis... here we come!].
    Castellano G
    G Ital Nefrol; 2008; 25(6):607. PubMed ID: 19048547
    [No Abstract]   [Full Text] [Related]  

  • 32. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis.
    Hartigan AJ; Westwick J; Jarai G; Hogaboam CM
    J Immunol; 2009 Oct; 183(8):5171-9. PubMed ID: 19783686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.
    Guiton R; Zagani R; Dimier-Poisson I
    Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal immunopathology. I. Experimental models. Analogy with human renal diseases].
    de Almedia DB; Habermann F
    Rev Hosp Clin Fac Med Sao Paulo; 1976 Oct; 31(5):399-406. PubMed ID: 981883
    [No Abstract]   [Full Text] [Related]  

  • 35. Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers.
    Mann DL; Celluzzi CM; Hankey KG; Harris KM; Watanabe R; Hasumi K
    Ann N Y Acad Sci; 2009 Sep; 1174():41-50. PubMed ID: 19769735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunology of renal disease.
    Pusey CD
    Practitioner; 1982 Dec; 226(1374):2063-73. PubMed ID: 7170300
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
    Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tipping the balance in glomerulonephritis.
    Salama AD
    J Am Soc Nephrol; 2005 May; 16(5):1169-71. PubMed ID: 15829706
    [No Abstract]   [Full Text] [Related]  

  • 40. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.
    Shale M; Ghosh S
    Gut; 2009 Sep; 58(9):1291-9. PubMed ID: 19671557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.